HB 4626
Vetoed
Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine
- West Virginia
- House / Assembly
- Introduced Jan 21, 2026
- Session 2026
Official Bill Page
Loading official bill page…
This state’s bills aren’t available here
West Virginia’s legislature doesn’t allow its bill pages to be shown on other sites. You can read the full bill on the official page.
View on official siteLegislative Timeline
36 actions-
Vetoed by Governor 4/1/2026
-
To Governor 3/31/2026
-
Vetoed by Governor 4/1/2026 - House Journal
-
Vetoed by Governor 4/1/2026 - Senate Journal
-
To Governor 3/31/2026 - Senate Journal
-
House received Senate message
-
Completed legislative action
-
Communicated to House
-
Passed Senate (Roll No. 487)
-
Read 3rd time
-
On 3rd reading
-
Read 2nd time
-
On 2nd reading
-
Read 1st time
-
On 1st reading
-
Reported do pass
-
To Finance
-
Reported do pass, but first to Finance
-
To Health and Human Resources
-
To Health and Human Resources then Finance
-
Introduced in Senate
-
Communicated to Senate
-
Passed House (Roll No. 32)
-
Read 3rd time
-
On 3rd reading, Special Calendar
-
Read 2nd time
-
On 2nd reading, Special Calendar
-
Read 1st time
-
On 1st reading, Special Calendar
-
On 1st reading, Special Calendar
-
Do pass
-
Markup Discussion
-
To House Health and Human Resources
-
Introduced in House
-
To Health and Human Resources
-
Filed for introduction